Grigg, J., Digre, K., Bernstein, P., Jamieson, R., Cornish, E., Mahajan, V., Geng, S., Yanavich, C., Fan, J., Liu, D., Zhao, Z., Zhang, S., Xu, C., Xu, T., Lichenstein, H., Solomons, N. (2026). Preliminary immunologic and clinical Phase 1b study outcomes from patients with ROSAH syndrome treated with the first-in-class ALPK1 inhibitor DF-003 2307448. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkag141.1377